Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), announced the results of a survey conducted during its recent webinar entitled “Optimizing Adaptive Trial Designs: Using Simulation Methodologies...
Perceptive Informatics Survey Results Reveal Top Barriers To Implementing Adaptive Trial Designs
BIO Members Committed To Ensuring Public Access To Key Clinical Trial Results
In testimony submitted to the National Institutes of Health (NIH), the Biotechnology Industry Organization (BIO) stressed the commitment of its member companies to help ensure that patients and health care providers have access to key clinical trial results information from trials of unapproved products. “BIO...
Experts From Molecular Imaging, Regulatory Agencies And Pharmaceutical Industry Come Together To Advance Multi-Center Drug Development Trials
More than 150 physicians, imagers and pharmaceutical developers convened in Clearwater, Fla., Feb. 8-9, for an intensive workshop examining the need for streamlined drug discovery through the integration of imaging biomarkers into multi-center clinical trials. Stakeholders from every facet of the drug...
Clinical Trials Workshop Maps Out Strategy For Effective Drug Development Studies
Day two of the SNM Clinical Trials Network Community Workshop convened on Monday, Feb. 9, in Clearwater, Fla., with more in-depth discussion on designing multicenter clinical trials using imaging biomarkers. “The workshop was designed to give members of the molecular imaging community an overview...
Neogenix Oncology To Begin First Clinical Trial For A New Generation Of Diagnostic Products
Neogenix Oncology, Inc. (Neogenix) announced today that the Institutional Review Board (IRB) at Conemaugh Valley Memorial Hospital (Memorial Medical Center) in Johnstown, Pennsylvania, has approved the company’s protocol for its first Diagnostic Clinical Trial. The study is designed to assess the...
Neogenix Oncology To Begin First Clinical Trial For A New Generation Of Diagnostic Products
Neogenix Oncology, Inc. (Neogenix) announced today that the Institutional Review Board (IRB) at Conemaugh Valley Memorial Hospital (Memorial Medical Center) in Johnstown, Pennsylvania, has approved the company’s protocol for its first Diagnostic Clinical Trial. The study is designed to assess the...
Misleading Media Coverage Of Medicine
Media coverage of clinical trials does not contain the elements readers require to make informed decisions. A comparison of the coverage received by pharmaceutical and herbal remedy trials, reported in the open access journal BMC Medicine, has revealed that it is rarely possible for the lay public to...
The Effects Of Disclosing Financial Interests On Participation In Medical Research
Knowing how an investigator is paid for running a research study surprisingly plays a small role in patients’ willingness to take part in clinical trials. However, according to a new Johns Hopkins University study more participants are troubled when they are told that the investigator could profit...
The Effects Of Disclosing Financial Interests On Participation In Medical Research
Knowing how an investigator is paid for running a research study surprisingly plays a small role in patients’ willingness to take part in clinical trials. However, according to a new Johns Hopkins University study more participants are troubled when they are told that the investigator could profit...
Clinical Trials: The Features And Promises Of The Brazilian Market
Frost & Sullivan will host a live briefing on Tuesday, September 23, at 3:00 pm EDT to provide industry participants an overview of a recently published study focusing on Clinical Trials Markets in Brazil. Over the years, Brazil has increasingly raised its attractiveness for pharmaceutical clinical...